Frankincense of Boswellia Sacra: Traditional and Modern Applied Uses, Pharmacological Activities, and Clinical Trials
Shaden A. M. Khalifa,Safaa M. Kotb,Shaden H. El-Seedi,Lutfun Nahar,Satyajit D. Sarker,Zhiming Guo,Xiaobo Zou,Syed G. Musharraf,Amir Reza Jassbi,Ming Du,Hesham R. El-Seedi
DOI: https://doi.org/10.1016/j.indcrop.2023.117106
IF: 6.449
2023-01-01
Industrial Crops and Products
Abstract:Since Boswellia sacra (Burseraceae) was studied in the 19th century, it has been known for its economic and cultural values. It is cultivated mainly in the southwest regions of Oman and some regions of Yemen, and is a natural source of frankincense, "Luban" in Arabic, around the world. Frankincense, the aromatic resin of B. sacra, is used widely both for traditional purposes and for the treatment of various ailments; e.g., dental infections, tumors, dysentery, vomiting, and fevers. Recently, many reports provided evidence for the potential biological activities of B. sacra, its synonym Boswellia carteri, and their constituent chemical compounds. These activities include cytotoxic, anti-inflammatory, antimicrobial, anti-diabetes, immunomodulatory, and anticoagulant effects. B. sacra was also tested for effects against gastric, hepatic, neurological, and skin disorders in vitro and in vivo. Clinical trials revealed good effects against carcinomas and gliomas, as well as against bladder and brain tumors. Its uses as a plant-based agent in nanotechnology displayed promising results. More efforts should be directed to further investigate these safe, plant-based bio-preservatives, and best practices should be outlined to protect these trees from extinction.